Anzeige
Mehr »
Login
Mittwoch, 08.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Diese Aktie hebt ab: +130,67% Kursgewinn in 1 Monat – das sind die Gründe
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
12 Leser
Artikel bewerten:
(0)

Vital Signs Loses Earnout Arbitration Case With Former HealthStar Pharmaceutical Services Shareholders


REVIER BEACH, Fla., Sept. 13 /PRNewswire/ -- In a 16 page decision rendered on August 11, 2006 the Arbitrator in the earnout dispute between Vital Signs and the former shareholders of HealthStar Pharmaceutical Services, Inc. acquired by Vital Signs in 1995 rendered an opinion in favor of the shareholders. The shareholders were awarded $915,333.00 in the decision. According to the terms of the 1995 Definitive Purchase Agreement between the companies the arbitration award is binding.

Background

On December 6, 1999 the former shareholders of HealthStar Pharmaceutical Services (HPS) represented by William J. Grabowski as Shareholder Representative filed suit in Federal District Court in Newark, New Jersey against Vital Signs, Inc. The suit alleged that Vital Signs conspired to deprive the former earnout shareholders of their additional payments by charging the earnings of HPS with the R & D costs of Vital Sign's failed Vasceze Catheter Flush product. In 2000 Vital Signs filed a motion with the court seeking to have the earnout dispute portion of the case heard in an arbitration format as provided by the contract. While the plaintiffs opposed the motion, on August 3, 2000 the Honorable John Bissell, United States District Judge ordered that the plaintiffs submit their claims to the binding audit process set forth in the agreement and administratively stayed all proceedings until the conclusion of the arbitration with the right to reopen the matter at that time.

In spite of the binding nature of the arbitration, Vital Signs has refused to pay the award. The plaintiffs are now assessing their options with the advice of their attorneys.

For additional information, please contact: William J. Grabowski 781-961-5400 ext. 104 Shareholder Representative for HealthStar Pharmaceutical Services

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2006 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.